Alumis Inc. (ALMS) vs Cullinan Therapeutics, Inc. (CGEM)
Alumis Inc. and Cullinan Therapeutics, Inc. are both Biotechnology companies. Alumis Inc. and Cullinan Therapeutics, Inc. are of similar size ($992.4M and $985.9M). Cullinan Therapeutics, Inc. has the higher net margin (0.00% vs −5,933.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Cullinan Therapeutics, Inc. leads on 8 and Alumis Inc. on 3.
Valuation
Profitability
| Metric | ALMS | CGEM | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (6,204.39%) | 0.00% | 0.00% |
| Net margin | (5,933.45%) | 0.00% | 0.00% |
| Free cash flow margin | (4,755.33%) | 0.00% | 0.00% |
| Return on equity | (93.65%) | (50.30%) | (57.72%) |
| Return on assets | (74.94%) | (46.30%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack